CVS Health price target raised to $80 from $73 at TD Cowen

CVS Health price target raised to $80 from $73 at TD Cowen

TD Cowen analyst Charles Rhyee raised CVS Health's price target to $80, rating it a Buy with a potential upside of +40%. The firm sees 2025 as a turnaround year due to successful bid process and benefits redesign.

Read More

Did you find this insightful?